脑卒中生物标志物的最新进展 - - 对预后和治疗的影响
Jessica Seetge1,2, Johannes Frenger1,2, Mira Katan1,2
1Department of Neurology and Stroke Center, University Hospital Basel.
Current opinion in neurology
|November 28, 2025
概括
最近的血液生物标志物有助于诊断急性缺血性中风,识别原因并预测结果. 进一步验证和整合是临床使用的关键,改善中风护理诊断,预后和治疗.
科学领域:
- 神经学 神经学
- 生物标志物发现发现
- 临床诊断 临床诊断 临床诊断
背景情况:
- 急性缺血性中风的诊断和管理需要准确的工具.
- 目前的诊断方法在速度和特异性方面存在局限性.
- 基于血液的生物标志物提供了潜在的进步.
研究的目的:
- 审查急性缺血性中风的基于血液的生物标志物的最新进展.
- 涵盖诊断,病因评估,风险预测和结果预测.
- 概述未来临床实施的方向.
主要方法:
- 关于基于血液的中风生物标志物的最新进展的文献综述.
- 在区分中风类型的生物标志物性能分析.
- 评估生物标志物用于病因分类和风险分层.
主要成果:
- 新的生物标志物改善了缺血性和出血性中风之间的差异化.
- 生物标志物有助于检测大血管堵塞,以优化分类.
- 特定的标记增强了病因分类,识别了诸如心血管栓塞等源.
- 循环标记物分层了血管复发和感染的风险.
- 预后生物标志物可以改进对功能结果和死亡率的预测.
结论:
- 标准化的样本采集和严格的验证对于临床转换至关重要.
- 为了实现全面的生物标志物实用性,需要多组学和面板集成.
- 基于血液的生物标志物具有改善中风诊断,预后和治疗的巨大潜力.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
763
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
763
Atherosclerosis IV: Nursing Management
347
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
347


